<html>
<head>
<meta http-equiv="Content-Type" content="text/html; charset=utf-8">
</head>
<body dir="auto">
<div>I don't understand your point, David. OSI is a cross stakeholder initiative....perhaps you aren't familiar with it or it's working groups.</div>
<div id="AppleMailSignature"><br>
</div>
<div id="AppleMailSignature">Gemma <br>
</div>
<div><br>
On 21 Jun 2017, at 20:46, David Prosser <<a href="mailto:david.prosser@rluk.ac.uk">david.prosser@rluk.ac.uk</a>> wrote:<br>
<br>
</div>
<blockquote type="cite">
<div>
<p><span style="color: #ff0000;"><strong>*** External email: use caution ***</strong></span></p>
<p> </p>
<div>So it is the responsibility of libraries to prove the harm to publishers? Odd
<div class=""><br class="">
<div class=""><span class="Apple-style-span" style="border-collapse: separate; color: rgb(0, 0, 0); font-family: Helvetica; font-style: normal; font-variant-ligatures: normal; font-variant-position: normal; font-variant-caps: normal; font-variant-numeric: normal; font-variant-alternates: normal; font-variant-east-asian: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: 2; text-align: -webkit-auto; text-indent: 0px; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; border-spacing: 0px; -webkit-text-decorations-in-effect: none; -webkit-text-stroke-width: 0px;">
<div style="word-wrap: break-word; -webkit-nbsp-mode: space; -webkit-line-break: after-white-space;" class="">
<span class="Apple-style-span" style="border-collapse: separate; color: rgb(0, 0, 0); font-family: Helvetica; font-style: normal; font-variant-ligatures: normal; font-variant-position: normal; font-variant-caps: normal; font-variant-numeric: normal; font-variant-alternates: normal; font-variant-east-asian: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: 2; text-align: -webkit-auto; text-indent: 0px; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; border-spacing: 0px; -webkit-text-decorations-in-effect: none; -webkit-text-stroke-width: 0px;">
<div style="word-wrap: break-word; -webkit-nbsp-mode: space; -webkit-line-break: after-white-space;" class="">
<span class="Apple-style-span" style="border-collapse: separate; color: rgb(0, 0, 0); font-family: Helvetica; font-style: normal; font-variant-ligatures: normal; font-variant-position: normal; font-variant-caps: normal; font-variant-numeric: normal; font-variant-alternates: normal; font-variant-east-asian: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: 2; text-align: -webkit-auto; text-indent: 0px; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; border-spacing: 0px; -webkit-text-decorations-in-effect: none; -webkit-text-stroke-width: 0px;">
<div style="word-wrap: break-word; -webkit-nbsp-mode: space; -webkit-line-break: after-white-space;" class="">
<span class="Apple-style-span" style="border-collapse: separate; color: rgb(0, 0, 0); font-family: Helvetica; font-style: normal; font-variant-ligatures: normal; font-variant-position: normal; font-variant-caps: normal; font-variant-numeric: normal; font-variant-alternates: normal; font-variant-east-asian: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: 2; text-align: -webkit-auto; text-indent: 0px; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; border-spacing: 0px; -webkit-text-decorations-in-effect: none; -webkit-text-stroke-width: 0px;">
<div style="word-wrap: break-word; -webkit-nbsp-mode: space; -webkit-line-break: after-white-space;" class="">
<span class="Apple-style-span" style="border-collapse: separate; color: rgb(0, 0, 0); font-family: Helvetica; font-style: normal; font-variant-ligatures: normal; font-variant-position: normal; font-variant-caps: normal; font-variant-numeric: normal; font-variant-alternates: normal; font-variant-east-asian: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: 2; text-align: -webkit-auto; text-indent: 0px; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; border-spacing: 0px; -webkit-text-decorations-in-effect: none; -webkit-text-stroke-width: 0px;">
<div style="word-wrap: break-word; -webkit-nbsp-mode: space; -webkit-line-break: after-white-space;" class="">
<span class="Apple-style-span" style="border-collapse: separate; color: rgb(0, 0, 0); font-family: Helvetica; font-style: normal; font-variant-ligatures: normal; font-variant-position: normal; font-variant-caps: normal; font-variant-numeric: normal; font-variant-alternates: normal; font-variant-east-asian: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: 2; text-indent: 0px; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; border-spacing: 0px; -webkit-text-decorations-in-effect: none; -webkit-text-stroke-width: 0px;">
<div style="word-wrap: break-word; -webkit-nbsp-mode: space; -webkit-line-break: after-white-space;" class="">
<span class="Apple-style-span" style="border-collapse: separate; color: rgb(0, 0, 0); font-family: Helvetica; font-style: normal; font-variant-ligatures: normal; font-variant-position: normal; font-variant-caps: normal; font-variant-numeric: normal; font-variant-alternates: normal; font-variant-east-asian: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: 2; text-indent: 0px; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; border-spacing: 0px; -webkit-text-decorations-in-effect: none; -webkit-text-stroke-width: 0px;">
<div style="word-wrap: break-word; -webkit-nbsp-mode: space; -webkit-line-break: after-white-space;" class="">
<span class="Apple-style-span" style="border-collapse: separate; color: rgb(0, 0, 0); font-family: Helvetica; font-style: normal; font-variant-ligatures: normal; font-variant-position: normal; font-variant-caps: normal; font-variant-numeric: normal; font-variant-alternates: normal; font-variant-east-asian: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: 2; text-indent: 0px; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; border-spacing: 0px; -webkit-text-decorations-in-effect: none; -webkit-text-stroke-width: 0px;">
<div style="word-wrap: break-word; -webkit-nbsp-mode: space; -webkit-line-break: after-white-space;" class="">
<span class="Apple-style-span" style="border-collapse: separate; color: rgb(0, 0, 0); font-family: Helvetica; font-style: normal; font-variant-ligatures: normal; font-variant-position: normal; font-variant-caps: normal; font-variant-numeric: normal; font-variant-alternates: normal; font-variant-east-asian: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: 2; text-indent: 0px; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; border-spacing: 0px; -webkit-text-decorations-in-effect: none; -webkit-text-stroke-width: 0px;">
<div style="word-wrap: break-word; -webkit-nbsp-mode: space; -webkit-line-break: after-white-space;" class="">
<span class="Apple-style-span" style="border-collapse: separate; color: rgb(0, 0, 0); font-family: Helvetica; font-style: normal; font-variant-ligatures: normal; font-variant-position: normal; font-variant-caps: normal; font-variant-numeric: normal; font-variant-alternates: normal; font-variant-east-asian: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: 2; text-indent: 0px; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; border-spacing: 0px; -webkit-text-decorations-in-effect: none; -webkit-text-stroke-width: 0px;">
<div style="word-wrap: break-word; -webkit-nbsp-mode: space; -webkit-line-break: after-white-space;" class="">
<br class="">
</div>
<div style="word-wrap: break-word; -webkit-nbsp-mode: space; -webkit-line-break: after-white-space;" class="">
<br class="">
</div>
</span></div>
</span></div>
</span></div>
</span></div>
</span></div>
</span></div>
</span></div>
</span></div>
</span></div>
</span></div>
<br class="">
<div>
<blockquote type="cite" class="">
<div class="">On 21 Jun 2017, at 18:58, Hersh, Gemma (ELS-CAM) <<a href="mailto:g.hersh@elsevier.com" class="">g.hersh@elsevier.com</a>> wrote:</div>
<br class="Apple-interchange-newline">
<div class="">
<div class="">Hi Danny<br class="">
<br class="">
I agree it would be helpful if we all had (additional) evidence all parties felt confident in. I had thought this was something you were leading on through OSI. Is that correct? If so, perhaps you could provide an update.<br class="">
<br class="">
Kind regards<br class="">
Gemma<br class="">
<br class="">
<br class="">
<br class="">
<blockquote type="cite" class="">On 21 Jun 2017, at 14:53, Dr D.A. Kingsley <<a href="mailto:dak45@cam.ac.uk" class="">dak45@cam.ac.uk</a>> wrote:<br class="">
<br class="">
*** External email: use caution ***<br class="">
<br class="">
<br class="">
<br class="">
Hi all,<br class="">
<br class="">
Gemma has identified several studies that talk about half life of articles<br class="">
in different disciplines. There is no dispute that these are interesting<br class="">
and probably accurate. However given there is **no causal arrow proven<br class="">
between half life and cancellation of subscriptions**. The half life<br class="">
furphy is irrelevant in the embargo discussion.<br class="">
<br class="">
I went through all of this in my blog in October 2015: "Half-life is half<br class="">
the story" <<a href="https://unlockingresearch.blog.lib.cam.ac.uk/?p=331" class="">https://unlockingresearch.blog.lib.cam.ac.uk/?p=331</a><br class="">
<br class="">
<br class="">
Now, let¹s turn our thoughts to the Œevidence¹ cited here:<br class="">
<br class="">
I am a bit shocked that the frankly dodgy 'study¹ that was done in 2012 is<br class="">
even being admitted to. This non peer reviewed Œstudy¹ consisted of one<br class="">
(leading and poorly worded) question going out to an undisclosed list of<br class="">
librarians around the world. The researcher was the Chair of the ALPSP<br class="">
Research Committee and was on the steering committee for the Publishers<br class="">
Research Coalition, raising questions about her (and the study¹s)<br class="">
objectivity. There are also major questions about the methodology of the<br class="">
study -<br class="">
<a href="http://poeticeconomics.blogspot.ch/2012/06/publishers-association-survey-on" class="">http://poeticeconomics.blogspot.ch/2012/06/publishers-association-survey-on</a><br class="">
.html In addition this ¹study' is being cited about Œpotential¹ effects,<br class="">
not actual effects. We are FIVE YEARS ON from this 'study¹, surely any<br class="">
Œpotential¹ effects would have started manifesting?<br class="">
<br class="">
The Journal of Clinical Investigation example. Hmmm. I also discussed this<br class="">
in my blog. The issue referred to here has nothing to do with the half<br class="">
life of research papers that are being made available open access through<br class="">
a repository. This refers to a journal that went to a GOLD Open Access<br class="">
model in 1996 (publishing open access and relying on non-subscription<br class="">
revenue sources), but eventually decided they needed to impose a<br class="">
subscription again in 2009. Not only is this example entirely unrelated to<br class="">
the embargo issue for green Open Access, it happened EIGHT YEARS AGO.<br class="">
<br class="">
In relation to the remaining three evidence of harm examples:<br class="">
<br class="">
* "The Annals of Mathematics experiment in green open access² example is a<br class="">
report from a workshop. Where is the actual study or link to support the<br class="">
statement made in this report? Where is the data? That¹s a strong<br class="">
statement and actual data would be useful. The way it is written seems to<br class="">
me to conflate some issues. When they say "an experiment in Œgreen¹" what<br class="">
does that mean? How closely does this relate to embargoes? It seems that a<br class="">
whole heap of things are tied up into one statement without any supporting<br class="">
data. This would not even pass first go of peer review in a paper. Or an<br class="">
undergraduate essay.<br class="">
<br class="">
<br class="">
* Is Elsevier willing to provide some actual data about the experience of<br class="">
the American Journal of Pathology? Where is this experience written up and<br class="">
published?<br class="">
<br class="">
<br class="">
* Is this the Genetics journal you are referring to?<br class="">
<a href="http://www.genetics.org/content/about-journal?">http://www.genetics.org/content/about-journal?</a> Again, where is this<br class="">
experience written up and published?<br class="">
<br class="">
It is concerning that people working for the largest academic publisher in<br class="">
the world seem to be ignorant of even basic logic within an argument and<br class="">
of the necessity to provide supporting data for a claim that is being made.<br class="">
<br class="">
<br class="">
<br class="">
We have here a hand picked tiny selection of Œexamples¹ (without<br class="">
supporting evidence) that are propping up the argument that research<br class="">
institutions around the world spend literally millions of<br class="">
pounds/dollars/whatever in terms of staff time to ensure that embargo<br class="">
periods are being observed across the entire corpus of publications.<br class="">
<br class="">
Embargoes are a very big sledgehammer to try and crack a very small nut.<br class="">
I¹d say the nut doesn¹t actually exist.<br class="">
<br class="">
Danny<br class="">
<br class="">
<blockquote type="cite" class=""><br class="">
Message: 2<br class="">
Date: Wed, 21 Jun 2017 07:59:14 +0000<br class="">
From: "Hersh, Gemma (ELS-CAM)" <<a href="mailto:g.hersh@elsevier.com">g.hersh@elsevier.com</a>><br class="">
Subject: Re: [GOAL] GOAL Digest, Vol 67, Issue 13<br class="">
To: "Global Open Access List (Successor of AmSci)" <<a href="mailto:goal@eprints.org">goal@eprints.org</a>><br class="">
Message-ID:<br class="">
<<a href="mailto:CY4PR08MB2838DDE2A0F737F9BFC1F6548FDA0@CY4PR08MB2838.namprd08.prod.outlo">CY4PR08MB2838DDE2A0F737F9BFC1F6548FDA0@CY4PR08MB2838.namprd08.prod.outlo</a><br class="">
<a href="http://ok.com">ok.com</a>><br class="">
<br class="">
Content-Type: text/plain; charset="iso-8859-1"<br class="">
<br class="">
Hi Danny<br class="">
<br class="">
<br class="">
<br class="">
This issue has been written about extensively and there have also been<br class="">
studies on this issue. I believe I may have previously consolidated and<br class="">
emailed to you all of the available evidence I am aware of, but I would<br class="">
be happy to do so (again) if helpful.<br class="">
<br class="">
<br class="">
<br class="">
Here is a selection for others that may be interested:<br class="">
<br class="">
<br class="">
<br class="">
Studies<br class="">
<br class="">
* In 2016, The Royal Historical Society in Response to the Stern<br class="">
Review of the UK Research Excellence Framework (REF) estimates that true<br class="">
download half-life of a history article is at least 12 years. Read<br class="">
more<<a href="http://royalhistsoc.org/response-stern-review-ref/">http://royalhistsoc.org/response-stern-review-ref/</a>><br class="">
* In 2014 Phil Davis published a study commissioned by the<br class="">
Association of American Publishers<br class="">
(Overview<<a href="http://www.publishers.org/usagestudy/">http://www.publishers.org/usagestudy/</a>>, Full<br class="">
Study<<a href="http://www.publishers.org/_attachments/docs/journalusagehalflife.pdf">http://www.publishers.org/_attachments/docs/journalusagehalflife.pdf</a><br class="">
<blockquote type="cite" class="">) which demonstrates that journal article usage varies widely within and<br class="">
across disciplines, and that only 3% of of journals have half-lives of<br class="">
12 months or less. Health sciences articles have the shortest median<br class="">
half-life of the journals analyzed, but still more than 50% of health<br class="">
science journals have usage half-lives longer than 24 months. In fields<br class="">
with the longest usage half-lives, including mathematics and the<br class="">
humanities, more than 50% of the journals have usage half-lives longer<br class="">
than 48 months.<br class="">
</blockquote>
<br class="">
<br class="">
<br class="">
Articles<br class="">
<br class="">
* Scholarly Kitchen<br class="">
article<<a href="http://scholarlykitchen.sspnet.org/2013/12/18/getting-open-access-">http://scholarlykitchen.sspnet.org/2013/12/18/getting-open-access-</a><br class="">
embargoes-right-rational-policy-must-be-evidence-based/?utm_source=feedbur<br class="">
ner&utm_medium=email&utm_campaign=Feed%3A+ScholarlyKitchen+%28The+Scholarl<br class="">
y+Kitchen%29>, Getting Open Access Embargoes Right: Rational Policy Must<br class="">
Be Evidence-Based<br class="">
* Scholarly Kitchen article, What is the Lifespan of a Research<br class="">
Article<<a href="http://scholarlykitchen.sspnet.org/2013/12/18/what-is-the-lifespan">http://scholarlykitchen.sspnet.org/2013/12/18/what-is-the-lifespan</a><br class="">
-of-a-research-article/?utm_source=feedburner&utm_medium=email&utm_campaig<br class="">
n=Feed%3A+ScholarlyKitchen+%28The+Scholarly+Kitchen%29>?<br class="">
* In 2014 the British Academy published a Study on Open Access in the<br class="">
Humanities and Social Sciences (<a href="http://www.britac.ac.uk/openaccess/">http://www.britac.ac.uk/openaccess/</a>) -<br class="">
shows that article half-lives are likely longer than previously<br class="">
suggested. A 1:2 ratio for embargo period lengths is concluded to be<br class="">
appropriate, but the dividing point should not be STEM:HSS, rather given<br class="">
the actual usage patterns of articles, it should be Medicine (1): HSS,<br class="">
Physics, Mathematics, Chemistry and Life Sciences (2). Suggested embargo<br class="">
lengths are 12 months (Biomedicine) and 24 months (all other fields).<br class="">
<br class="">
<br class="">
Evidence of harm<br class="">
<br class="">
* Journal of Clinical Investigation - went open access with a 0 month<br class="">
embargo in 1996 and lost c. 40% of institutional subscriptions. It<br class="">
blighted the economics of the journal which was forced to return to the<br class="">
subscription model in 2009:<br class="">
<a href="http://scholarlykitchen.sspnet.org/2009/02/26/end-of-free-access/">http://scholarlykitchen.sspnet.org/2009/02/26/end-of-free-access/</a><br class="">
* The Annals of Mathematics experiment in green open access was a<br class="">
sobering lesson: libraries cancelled 34% of the subscriptions between<br class="">
2003 and 2008 when the journal was freely available online. The Annals is<br class="">
one of the very best journals in mathematics and one of the cheapest<br class="">
journals; and so it came as a surprise to many that some of the best-<br class="">
funded libraries in the US had decided to save on the subscription rather<br class="">
than support the experiment in widening access. A mathematics workshop<br class="">
suggested research community support for a 5 year embargo period in this<br class="">
field given that arXiv is also available. See<br class="">
<a href="http://www.msri.org/attachments/workshops/587/MSRIfinalreport.pdf">http://www.msri.org/attachments/workshops/587/MSRIfinalreport.pdf</a><br class="">
* American Journal of Pathology lengthened its embargo period and<br class="">
began working with a commercial publisher because of the negative impact<br class="">
on subscriptions of a 6 month embargo.<br class="">
* Genetics has increased its embargo period from 3, then to 6, then<br class="">
to 12 months because of a negative impact on subscriptions. They have<br class="">
needed to balance a 12 month embargo with the addition of an author<br class="">
payment in order to make this embargo length work - even though they<br class="">
publish in the life sciences.<br class="">
<br class="">
<br class="">
Evidence for the potential effect of embargoes on cancellations<br class="">
<br class="">
* In 2012, was a simple one-question survey by ALPSP: "If the<br class="">
(majority of) content of research journals was freely available within 6<br class="">
months of publication, would you continue to subscribe?" The results<br class="">
"indicate that only 56% of those subscribing to journals in the STM field<br class="">
would definitely continue to subscribe. In AHSS, this drops to just 35%.<br class="">
" More information is available on the ALPSP site and in embedded links<br class="">
here<<a href="http://www.alpsp.org/ebusiness/AboutALPSP/ALPSPStatements/Statementde">http://www.alpsp.org/ebusiness/AboutALPSP/ALPSPStatements/Statementde</a><br class="">
tails.aspx?ID=407>. This result builds on earlier, more nuanced studies<br class="">
undertaken for ALPSP in 2009 and 2006 and by PRC in 2006.<br class="">
<br class="">
<br class="">
<br class="">
Kind regards<br class="">
<br class="">
Gemma<br class="">
<br class="">
<br class="">
<br class="">
-----Original Message-----<br class="">
From: <a href="mailto:goal-bounces@eprints.org">goal-bounces@eprints.org</a> [<a href="mailto:goal-bounces@eprints.org">mailto:goal-bounces@eprints.org</a>] On<br class="">
Behalf Of Dr D.A. Kingsley<br class="">
Sent: 20 June 2017 21:18<br class="">
To: <a href="mailto:goal@eprints.org">goal@eprints.org</a><br class="">
Subject: Re: [GOAL] GOAL Digest, Vol 67, Issue 13<br class="">
<br class="">
<br class="">
<br class="">
*** External email: use caution ***<br class="">
<br class="">
<br class="">
<br class="">
<br class="">
<br class="">
<br class="">
<br class="">
Gemma,<br class="">
<br class="">
<br class="">
<br class="">
Please provide evidence for your statement "an embargo period is needed<br class="">
to enable the subscription model to continue to operate, in the absence<br class="">
of a separate business model? other than it sounds like it *probably*<br class="">
should be true.<br class="">
<br class="">
<br class="">
<br class="">
We all thought cough medicine should work until someone tested it.<br class="">
<br class="">
<br class="">
<br class="">
Danny<br class="">
<br class="">
<br class="">
<br class="">
Dr Danny Kingsley<br class="">
<br class="">
Head, Office of Scholarly Communication<br class="">
<br class="">
Cambridge University LibraryWest Road, CB3 9DR<br class="">
<br class="">
e: <a href="mailto:dak45@cam.ac.uk">dak45@cam.ac.uk</a><<a href="mailto:dak45@cam.ac.uk">mailto:dak45@cam.ac.uk</a>><br class="">
<br class="">
p: 01223 747 437<br class="">
<br class="">
m: 07711 500 564<br class="">
<br class="">
t: @dannykay68<br class="">
<br class="">
w: <a href="http://www.osc.cam.ac.uk">www.osc.cam.ac.uk</a><<a href="http://www.osc.cam.ac.uk">http://www.osc.cam.ac.uk</a>><br class="">
<br class="">
b: <a href="https://unlocking">https://unlocking</a> research.blog.lib.cam.ac.uk<br class="">
<br class="">
o: <a href="http://orcid.org/0000-0002-3636-5939">orcid.org/0000-0002-3636-5939</a><br class="">
</blockquote>
<br class="">
Dr Danny Kingsley<br class="">
Head, Office of Scholarly Communication<br class="">
Cambridge University LibraryWest Road, CB3 9DR<br class="">
e: <a href="mailto:dak45@cam.ac.uk">dak45@cam.ac.uk</a><br class="">
p: 01223 747 437<br class="">
m: 07711 500 564t: @dannykay68<br class="">
w: <a href="http://www.osc.cam.ac.uk">www.osc.cam.ac.uk</a><br class="">
b: <a href="https://unlocking">https://unlocking</a> research.blog.lib.cam.ac.uk<br class="">
o: <a href="http://orcid.org/0000-0002-3636-5939">orcid.org/0000-0002-3636-5939</a><br class="">
<br class="">
<br class="">
_______________________________________________<br class="">
GOAL mailing list<br class="">
<a href="mailto:GOAL@eprints.org">GOAL@eprints.org</a><br class="">
<a href="http://mailman.ecs.soton.ac.uk/mailman/listinfo/goal">http://mailman.ecs.soton.ac.uk/mailman/listinfo/goal</a><br class="">
</blockquote>
<br class="">
________________________________<br class="">
<br class="">
Elsevier Limited. Registered Office: The Boulevard, Langford Lane, Kidlington, Oxford, OX5 1GB, United Kingdom, Registration No. 1982084, Registered in England and Wales.<br class="">
<br class="">
_______________________________________________<br class="">
GOAL mailing list<br class="">
<a href="mailto:GOAL@eprints.org" class="">GOAL@eprints.org</a><br class="">
<a href="http://mailman.ecs.soton.ac.uk/mailman/listinfo/goal">http://mailman.ecs.soton.ac.uk/mailman/listinfo/goal</a><br class="">
</div>
</div>
</blockquote>
</div>
<br class="">
</div>
</div>
</div>
</blockquote>
<blockquote type="cite">
<div><span>_______________________________________________</span><br>
<span>GOAL mailing list</span><br>
<span><a href="mailto:GOAL@eprints.org">GOAL@eprints.org</a></span><br>
<span><a href="http://mailman.ecs.soton.ac.uk/mailman/listinfo/goal">http://mailman.ecs.soton.ac.uk/mailman/listinfo/goal</a></span><br>
</div>
</blockquote>
<style>P {margin:0cm:margin-bottomL.0001pt;}</style><br>
<hr>
<p><span style="font-size:10pt;font-family:"Arial","sans-serif"">Elsevier Limited. Registered Office: The Boulevard, Langford Lane, Kidlington, Oxford, OX5 1GB, United Kingdom, Registration No. 1982084, Registered in England and Wales.</span>
<br clear="none">
</p>
</body>
</html>